Insufficient Quantities. In the event that a Party determines that there are insufficient quantities of the Corvus Molecule or the Genentech Molecule to reach Study Completion, such Party shall promptly provide written notice to the other Party, including what quantities of its Molecule, if any, are available for the Study. The JDC will promptly discuss how to address the shortage and allocate the available amounts of Corvus Molecule or Genentech Molecule, as applicable. Notwithstanding the foregoing, [***].
Appears in 4 contracts
Samples: Ib Combination Study Agreement (Corvus Pharmaceuticals, Inc.), Combination Study Agreement (Corvus Pharmaceuticals, Inc.), Ib Combination Study Agreement (Corvus Pharmaceuticals, Inc.)
